Events

Upcoming Events

San Diego, CA and virtual
|
Apr 5- Apr 10, 2024

PROGRAM COMMITTEE CHAIRS

Keith T. Flaherty, Harvard Medical School, Boston, Massachusetts
Christina Curtis, Stanford University, Stanford, California

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

More information about the AACR Annual Meeting 2024 will be available online and in the Call for Abstracts in late August 2023.

New York, NY
|
Apr 11- Apr 13, 2024

"The thymus: from biology to medicine and back"

Rockville, MD
|
Apr 23- Apr 23, 2024

The NCI RNA Biology Initiative aims to facilitate the rapid exchange of information and expertise on the structure, function, biological roles, and therapeutic uses of RNA. Our goal is to foster synergistic interactions amongst NIH investigators and between NIH investigators and the larger scientific community. We anticipate that new insights into RNA biology and the development of innovative RNA-based tools and therapies will both define novel targets and accelerate the implementation of therapeutic interventions in cancer.

This one-day workshop will bring together leaders from industry, academia, and government with expertise in therapeutic oligonucleotides, delivery, small molecules, and preclinical development of novel RNA-based and RNA-targeted therapies.

London, UK
|
Apr 23- Apr 25, 2024

With a comprehensive agenda encompassing four distinct yet related programs - Modulating the Tumour Microenvironment, Next Generation Cell-Based Immunotherapies, Bispecific and Multi-specific Antibody Therapeutics and Therapeutic Cancer Vaccines, the Summit promises to be a forum for the exchange of cutting-edge research, and a platform for collaboration among the global immuno-oncology community.

Highlights include a plenary keynote session featuring 2 distinguished speakers; engaging breakout discussions that bring peers together to chat about the most pressing or contentious topics; a balanced faculty of industry and academia speakers; posters showcasing innovative studies and an Exhibit Hall gathering the technology leaders in the IO space.

London, UK
|
Apr 25- Apr 26, 2024

A two-day event packed with leading speakers, research and cutting-edge presentations on the latest advancements in the discovery & development of cancer immunotherapies with dedicated sessions on different therapeutic modalities, biomarkers, precision and omics-based approaches in IO as well as case studies on innovative preclinical and translational tools.

Kerry, Ireland and On Demand
|
May 6- May 9, 2024

This meeting will focus on myeloid cells with or without antigen presenting cell (APC) function, including dendritic cells, macrophages and monocyte-derived cells which have both the ability to shape the immune microenvironment of tumor lesions and instruct T cell effector and regulatory programs. The program will highlight the diversity of the tumor-associated APC compartment and describe its cellular and molecular composition and spatial distribution in tumor lesions.

Mainz, Germany
|
May 15- May 17, 2024

Welcome to Europe’s largest meeting focused on cancer immunotherapy research and development. Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT invites international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy.

New York, NY
|
May 21- May 23, 2024

With rapid change in the field of cancer immunotherapy, Frontiers in Cancer Immunotherapy 2024 aims to shed light on promising novel therapies for patients with cancer. While the field has seen many successes over the last few years, challenges remain in understanding the basic biology of some tumor types and in identifying targets for developing novel therapies.

This symposium presents a remarkable opportunity to convene with other researchers, clinicians, and industry leaders to discuss the extraordinary progress and immense potential of new drug therapies and technologies in paving the way for a brighter future in cancer treatment.

Chicago, IL and virtual
|
May 31- Jun 4, 2024

The 2024 ASCO Annual Meeting Program will feature over 200 sessions complementing Dr. Lynn Schuchter’s Presidential theme: The Art and Science of Cancer Care: From Comfort to Cure.

Boston, MA
|
Jun 24- Jun 27, 2024

Arthur, Sandra and Sarah Irving together with the Mass General Cancer Center are excited to announce the third annual “Arthur and Sandra Irving Cancer Immunology Symposium” to be held on June 24-27, 2024. The Symposium will bring together about 15 accomplished faculty mentors who are excited to share their discoveries and research career experience in cancer immunology with approximately 45 promising young scientists (post-docs and starting PIs).

Deadline: Friday, January 5, 2024

National Harbor, MD
|
Sep 8- Sep 11, 2024

Come discuss the latest strides in the dynamic field of cancer immunotherapy. Join the leaders in cancer immunology as they unveil groundbreaking insights during plenary sessions and proffered talks curated from the abstract submissions.

Conference Co-Chairpersons

Elizabeth M. Jaffee, Johns Hopkins Medicine

Guido Kroemer, Gustave Roussy Cancer Center

Dana Pe’er, Memorial Sloan Kettering Cancer Center

Özlem Türeci, BioNTech

Barcelona, Spain
|
Sep 13- Sep 17, 2024

ESMO 2024 will disseminate the latest cutting-edge data, provide high quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.

Boston, MA
|
Oct 18- Oct 21, 2024

CONFERENCE COCHAIRS

Yvonne Y. Chen, University of California, Los Angeles, California

Sergio Quezeda, University College London (UCL) Cancer Institute, London, England

Robert D. Schreiber, Washington University School of Medicine of St. Louis, St. Louis, Missouri

Fernando Vidal-Vanaclocha, The George Washington University, Washington, D.C.

Houston, TX
|
Nov 6- Nov 10, 2024

Member registration opens April 2024; non-member registration opens in May 2024.

Leipzig, Germany
|
Nov 12- Nov 13, 2024

The Leipzig Immune ONcology (LION) Conference will focus on the latest developments in immune oncology and provide a forum for leading scientists, clinicians, and industry professionals to exchange ideas and discuss new findings in this exciting field. We invite you to submit your abstracts for oral and poster presentations at the conference. In addition to a stimulating scientific program, the conference will feature networking opportunities, including a welcome reception and poster sessions, as well as an industry exhibition showcasing the latest technologies and services related to cancer immunotherapy research. The LION Conference is organized by the Fraunhofer Institute for Cell Therapy and Immunology IZI and the University Hospital Leipzig. We are looking forward to welcoming you in Leipzig this November and to hearing about your latest research in immune oncology.

Boston, MA
|
Nov 17- Nov 20, 2024

CONFERENCE COCHAIRS:

Mikala Egeblad, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York

Neta Erez, Tel Aviv University, Tel Aviv, Israel

Sergei I. Grivennikov, Cedars-Sinai Medical Center, Los Angeles, California

Ilaria Malanchi, The Francis Crick Institute, London, England

Vancouver, Canada
|
Feb 2- Feb 5, 2025

Normal and pathological immune responses function across tissues that harbor unique metabolic, environmental, and cellular microenvironments. Therefore the mechanisms that recruit and activate leukocytes, define their interstitial function and survival, or promote their retention in particular tissues are crucial to understanding how to boost, redirect, or restrict immune responses across the spectrum of health and disease. While the topic of tissue specific immunity has been touched on in other meetings, this is the first conference to integrate discussion across diverse tissues and disease contexts. The program will cover how various tissues shape the immune responses that are generated within, while highlighting emerging technologies that are enabling advancements in this field.

Close Modal

Small change for you. Big change for us!

This Thanksgiving season, show your support for cancer research by donating your change.

In less than a minute, link your credit card with our partner RoundUp App.

Every purchase you make with that card will be rounded up and the change will be donated to ACIR.

All transactions are securely made through Stripe.